Skip to content

Share Buybacks at other companies

Universal Health Services logo
Universal Health ServicesUHS
$163.85M-26.7%
Tenet Healthcare logo
Tenet HealthcareTHC
$318M-8.6%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$100M
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$60M+456%
HCA Healthcare logo
HCA HealthcareHCA
$1.57B-37.3%
Progyny logo
ProgynyPGNY
$118.61M

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's share buybacks?
Pediatrix Medical Group (MD) reported share buybacks of $21.45M in Q1 2026.
How has Pediatrix Medical Group's share buybacks changed year-over-year?
Pediatrix Medical Group's share buybacks increased by 1267.2% year-over-year, from $1.57M to $21.45M.
What is the long-term trend for Pediatrix Medical Group's share buybacks?
Over 4 years (2021 to 2025), Pediatrix Medical Group's share buybacks has grown at a 107.0% compound annual growth rate (CAGR), from $4.72M to $86.68M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.